1Cohen D, Weintrob N, Benzaquen H, et al. Continuous subcutaneous insulin infusion versus multiple daily injections in adolescents with type 1 diabetes mellitus: a randomized open crossover trial. J Pediatr Endocrinol Metab. 2003;16(7):1047-1050. https://doi.org/10.1515/JPEM.2003.16.7.1047
2Weintrob N, Benzaquen H, Galatzer A, et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics. 2003;112(3):559-564. http://dx.doi.org/10.1542/peds.112.3.559
3DiMeglio LA, Pottorff TM, Boyd SR, et al. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr. 2004;145(3):380-384. https://doi.org/10.1016/j.jpeds.2004.06.022
4Wilson DM, Buckingham BA, Kunselman EL, et al. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care. 2005;28(1):15-19. http://dx.doi.org/10.2337/diacare.28.1.15
5Ahern JA, Boland EA, Doane R, et al. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatr Diabetes. 2002;3(1):10-15. http://dx.doi.org/10.1034/j.1399-5448.2002.30103.x
6Berhe T, Postellon D, Wilson B, Stone R. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study. Pediatrics. 2006;117(6):2132-2137. http://dx.doi.org/10.1542/peds.2005-2363
7Schiaffini R, Ciampalini P, Spera S, et al. An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes. Diabetes Metab Res Rev. 2005;21(4):347-352. http://dx.doi.org/10.1002/dmrr.520
8Sulli N, Shashaj B. Long-term benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes: a 4-year follow-up. Diabet Med. 2006;23(8):900-906. http://dx.doi.org/10.1111/j.1464-5491.2006.01935.x
9Delvecchio M, Zecchino C, Salzano G, et al. Effects of moderate-severe exercise on blood glucose in type 1 diabetic adolescents treated with insulin pump or glargine insulin. J Endocrinol Invest. 2009;32(6):519-524. http://dx.doi.org/10.1007/BF03346499
10Tubiana-Rufi N, Coutant R, Bloch J, et al. Special management of insulin lispro in continuous subcutaneous insulin infusion in young diabetic children: a randomized cross-over study. Horm Res Paediatr. 2004;62(6):265-271. http://dx.doi.org/10.1159/000081703
11Schiaffini R, Ciampalini P, Spera S, et al. Efficacy and safety of rapid acting insulin analogues in diabetic children and adolescents treated with continuous subcutaneous insulin infusion (CSII) [abstract]. Diabetes. 2002;51(suppl 2):A610.
12Weinzimer SA, Ternand C, Howard C, et al. A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes. Diabetes Care. 2008;31(2):210-215. http://doi.org/10.2337/dc07-1378
13Swan KL, Dziura JD, Steil GM, et al. Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care. 2009;32(2):240-244. http://dx.doi.org/10.2337/dc08-0595